Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' STAMBLER BS' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 76 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Varma, N; Stambler, BS
      Recurrence of supraventricular tachycardia after slow pathway ablation foratrioventricular nodal reentrant tachycardia: What is the mechanism?

      JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY
    2. Ellenbogen, KA; Stambler, BS; Orav, EJ; Sgarbossa, EB; Tullo, NG; Love, CA; Wood, MA; Goldman, L; Lamas, GA
      Clinical characteristics of patients intolerant to VVIR pacing

      AMERICAN JOURNAL OF CARDIOLOGY
    3. Fenelon, G; Ellenbogen, KA; Wood, MA; Stambler, BS
      Mechanism of atrial flutter conversion by class III antiarrhythmic drugs

      MONOPHASIC ACTION POTENTIALS: BRIDGING CELL AND BEDSIDE
    4. Clemo, HF; Stambler, BS; Baumgarten, CM
      Swelling-activated chloride current is persistently activated in ventricular myocytes from dogs with tachycardia-induced congestive heart failure

      CIRCULATION RESEARCH
    5. Ellenbogen, KA; Wood, MA; Stambler, BS
      Intravenous therapy for atrial fibrillation: More choices, more questions,more trials

      AMERICAN HEART JOURNAL
    6. FENELON G; MANDERS T; STAMBLER BS
      RECOVERY FROM PACING-INDUCED HEART-FAILURE IS ASSOCIATED WITH PERSISTENCE OF TRIGGERED ATRIAL TACHYCARDIA IN SPITE OF NORMALIZATION OF ATRIAL REFRACTORINESS AND VENTRICULAR-FUNCTION

      Journal of the American College of Cardiology
    7. SHEPARD RK; NATALE A; STAMBLER BS; WOOD MA; GILLIGAN DM; ELLENBOGEN KA
      PHYSIOLOGY OF THE ESCAPE RHYTHM AFTER RADIOFREQUENCY ATRIOVENTRICULARJUNCTIONAL ABLATION

      PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY
    8. LAMAS GA; ORAV J; STAMBLER BS; ELLENBOGEN KA; SGARBOSSA EB; HUANG SKS; MARINCHAK RA; ESTES NAM; MITCHELL GF; LIEBERMAN EH; MANGIONE CM; GOLDMAN L
      QUALITY-OF-LIFE AND CLINICAL OUTCOMES IN ELDERLY PATIENTS TREATED WITH VENTRICULAR PACING AS COMPARED WITH DUAL-CHAMBER PACING

      The New England journal of medicine
    9. CLEMO HF; STAMBLER BS; BAUMGARTEN CM
      PERSISTENT ACTIVATION OF A SWELLING-ACTIVATED CATION CURRENT IN VENTRICULAR MYOCYTES FROM DOGS WITH TACHYCARDIA-INDUCED CONGESTIVE-HEART-FAILURE

      Circulation research
    10. STAMBLER BS; ELLENBOGEN KA
      ATRIAL-FLUTTER CYCLE LENGTH OSCILLATIONS AND ROLE OF THE AUTONOMIC NERVOUS-SYSTEM - RESPONSE

      Circulation
    11. CLEMO HF; STAMBLER BS; BAUMGARTEN CM
      SWELLING-ACTIVATED CHLORIDE CURRENT AND MYOCYTE VOLUME IN EXPERIMENTAL CONGESTIVE-HEART-FAILURE

      Biophysical journal
    12. WOOD MA; STAMBLER BS; ELLENBOGEN KA; GILLIGAN DM; PERRY KT; WAKEFIELD LK; VANDERLUGT JT
      SUPPRESSION OF INDUCIBLE VENTRICULAR-TACHYCARDIA BY IBUTILIDE IN PATIENTS WITH CORONARY-ARTERY DISEASE

      The American heart journal
    13. STAMBLER BS; SHEPARD RK; TURNER DA; FENELON G
      CHRONIC ATRIAL DILATATION INDUCES PROLONGATION OF ATRIAL REFRACTORINESS AND ATRIAL TACHYARRHYTHMIAS

      Journal of the American College of Cardiology
    14. STAMBLER BS; SHEPARD RK; TUMER DA; FENELON G
      EVIDENCE OF TRIGGERED ACTIVITY AS THE MECHANISM OF ATRIAL TACHYCARDIAIN DOGS WITH PACING-INDUCED HEART-FAILURE

      Journal of the American College of Cardiology
    15. FENELON G; MANDERS T; STAMBLER BS
      ATRIAL TACHYCARDIA IN DOGS WITH VENTRICULAR PACING-INDUCED CONGESTIVE-HEART-FAILURE ORIGINATES FROM MULTIPLE FOCI IN THE CRISTA TERMINALIS AND PULMONARY VEINS - EXPERIMENTAL-EVIDENCE SUPPORTING THE ATRIAL-RING-OF-FIRE HYPOTHESIS

      Circulation
    16. FENELON G; HUVELLE E; BRUGADA P; STEVENSON WG; STAMBLER BS
      VENTRICULAR REFRACTORINESS IS PROLONGED IN HUMAN HEART-FAILURE - ANALYSIS OF THE VENTRICULAR-FIBRILLATION INTERVALS FROM IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS

      Circulation
    17. STAMBLER BS; WOOD MA; ELLENBOGEN KA
      ANTIARRHYTHMIC ACTIONS OF INTRAVENOUS IBUTILIDE COMPARED WITH PROCAINAMIDE DURING HUMAN ATRIAL-FLUTTER AND FIBRILLATION - ELECTROPHYSIOLOGICAL DETERMINANTS OF ENHANCED CONVERSION EFFICACY

      Circulation
    18. BELZ MK; STAMBLER BS; WOOD MA; PHERSON C; ELLENBOGEN KA
      EFFECTS OF ENHANCED PARASYMPATHETIC TONE ON ATRIOVENTRICULAR NODAL CONDUCTION DURING ATRIOVENTRICULAR NODAL REENTRANT TACHYCARDIA

      The American journal of cardiology
    19. ELLENBOGEN KA; EPSTEIN AE; WOOD MA; STAMBLER BS; KAY GN; PLUMB VJ; VOSHAGESTAHL L; HULL ML
      ARE MORE COMPLEX IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS ASSOCIATED WITH AN INCREASED MORTALITY - LESSONS LEARNED FROM CLINICAL-TRIALS

      The American journal of cardiology
    20. STAMBLER BS; BECKMAN KJ; KADISH AH; CAMM JA; ELLENBOGEN KA; PERRY KT; VANDERLUGT JT
      ACUTE HEMODYNAMIC-EFFECTS OF INTRAVENOUS IBUTILIDE IN PATIENTS WITH OR WITHOUT REDUCED LEFT-VENTRICULAR FUNCTION

      The American journal of cardiology
    21. KONTOS MC; ELLENBOGEN KA; WOOD MA; DAMIANO RJ; AKOSAH KO; NIXON JV; STAMBLER BS
      FACTORS ASSOCIATED WITH ELEVATED IMPEDANCE WITH A NONTHORACOTOMY DEFIBRILLATION LEAD SYSTEM

      The American journal of cardiology
    22. CLEMO HF; BAUMGARTEN CM; ELLENBOGEN KA; STAMBLER BS
      ATRIAL-NATRIURETIC-PEPTIDE AND CARDIAC ELECTROPHYSIOLOGY - AUTONOMIC AND DIRECT EFFECTS

      Journal of cardiovascular electrophysiology
    23. ELLENBOGEN KA; STAMBLER BS; WOOD MA
      EFFICACY OF INTRAVENOUS IBUTILIDE FOR RAPID TERMINATION OF ATRIAL-FIBRILLATION AND ATRIAL-FLUTTER - A DOSE-RESPONSE STUDY (VOL 28, PG 130, 1996)

      Journal of the American College of Cardiology
    24. ELLENBOGEN KA; STAMBLER BS; WOOD MA; SAGER PT; WESLEY RC; MEISSNER MD; ZOBLE RG; WAKEFIELD LK; PERRY KT; VANDERLUGT JT
      EFFICACY OF INTRAVENOUS IBUTILIDE FOR RAPID TERMINATION OF ATRIAL-FIBRILLATION AND ATRIAL-FLUTTER - A DOSE-RESPONSE STUDY

      Journal of the American College of Cardiology
    25. GUO GBF; ELLENBOGEN KA; WOOD MA; STAMBLER BS
      CONVERSION OF ATRIAL-FLUTTER BY IBUTILIDE IS ASSOCIATED WITH INCREASED ATRIAL CYCLE LENGTH VARIABILITY

      Journal of the American College of Cardiology
    26. STAMBLER BS; WOOD MA; ELLENBOGEN KA
      PHARMACOLOGICAL ALTERATIONS IN HUMAN TYPE-I ATRIAL-FLUTTER CYCLE LENGTH AND MONOPHASIC ACTION-POTENTIAL DURATION - EVIDENCE OF A FULLY EXCITABLE GAP IN THE REENTRANT CIRCUIT

      Journal of the American College of Cardiology
    27. LAWTON JS; WOOD MA; GILLIGAN DM; STAMBLER BS; DAMIANO RJ; ELLENBOGEN KA
      IMPLANTABLE TRANSVENOUS CARDIOVERTER-DEFIBRILLATOR LEADS - THE DARK SIDE

      PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY
    28. ELLENBOGEN KA; WOOD MA; STAMBLER BS; BERNSTEIN R; HERRE J; CAMERON D; DOWNAR E; GILLIAM F; GOLD M; LEONELLI F; LEVANOVICH P; RADTKE N; SPERRY R; WINTERS S; WORLEY S
      ACUTE EFFECTS OF RADIOFREQUENCY ABLATION OF ATRIAL ARRHYTHMIAS ON IMPLANTED PERMANENT PACING SYSTEMS

      PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY
    29. WOOD MA; MOSKOVLJEVIC P; STAMBLER BS; ELLENBOGEN KA
      COMPARISON OF BIPOLAR ATRIAL ELECTROGRAM AMPLITUDE IN SINUS RHYTHM, ATRIAL-FIBRILLATION, AND ATRIAL-FLUTTER

      PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY
    30. STAMBLER BS; WOOD MA; ELLENBOGEN KA
      LIMITATIONS OF TACHYCARDIA CONFIRMATION AND RATE CLASSIFICATION ALGORITHMS IN A 3RD-GENERATION IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR

      PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY
    31. SPERRY RE; STAMBLER BS; WOOD MA; CYCAN A; ELLENBOGEN KA
      REDUCTION OF ANTIARRHYTHMIC DRUG-USE IN PATIENTS RECEIVING IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS

      PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY
    32. ELLENBOGEN KA; STAMBLER BS; ORAV EJ; SGARBOSSA E; TULLO NG; LOVE C; LAMAS GA; WOOD MA
      CLINICAL CHARACTERIZATION OF PATIENT CROSSOVERS TO DDDR PACING DURINGDDDR VERSUS VVIR PACING IN THE PASE TRIAL - INSIGHTS INTO PACEMAKER SYNDROME

      Circulation
    33. STAMBLER BS; WOOD MA; ELLENBOGEN KA; PERRY KT; WAKEFIELD LK; VANDERLUGT JT; ABISAMRA FM; AHERN TS; BURGER AJ; CASSIDY DM; DENKER ST; DIMARCO JP; FLOWERS NC; SRIDHARAN R; HESSEN SH; KALBFLEISCH JM; KOWEY PR; MATTIONI TA; MEISSNER MD; PORTNOW AS; STRATTON SS; SAGER PT; SHARMA AD; WESLEY RC; WINDLE JR; ZOBLE RG
      EFFICACY AND SAFETY OF REPEATED INTRAVENOUS DOSES OF IBUTILIDE FOR RAPID CONVERSION OF ATRIAL-FLUTTER OR FIBRILLATION

      Circulation
    34. STAMBLER BS; ELLENBOGEN KA
      ELUCIDATING THE MECHANISMS OF ATRIAL-FLUTTER CYCLE LENGTH VARIABILITYUSING POWER SPECTRAL-ANALYSIS TECHNIQUES

      Circulation
    35. LAWTON JS; ELLENBOGEN KA; WOOD MA; STAMBLER BS; HERRE JM; NATH S; BERNSTEIN RC; DIMARCO JP; HAINES DE; SZENTPETERY S; BAKER LD; DAMIANO RJ
      SENSING LEAD-RELATED COMPLICATIONS IN PATIENTS WITH TRANSVENOUS IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS

      The American journal of cardiology
    36. BLACKSHEAR JL; STAMBLER BS; STRAUSS WE; ROY D; DIAS VC; BEACH CL; EBENER MK
      CONTROL OF HEART-RATE DURING TRANSITION FROM INTRAVENOUS OF ORAL DILTIAZEM IN FIBRILLATION OR FLUTTER

      The American journal of cardiology
    37. OLSOVSKY MR; BELZ MK; STAMBLER BS; GILLIGAN DM; WOOD MA; ELLENBOGEN KA
      SELECTIVE SLOW PATHWAY ABLATION DOES NOT ALTER ENHANCEMENT OF VAGAL TONE ON SINUS AND ATRIOVENTRICULAR NODAL FUNCTION

      The American journal of cardiology
    38. STAMBLER BS; WOOD MA; ELLENBOGEN KA
      COMPARATIVE EFFICACY OF INTRAVENOUS IBUTILIDE VERSUS PROCAINAMIDE FORENHANCING TERMINATION OF ATRIAL-FLUTTER BY ATRIAL OVERDRIVE PACING

      The American journal of cardiology
    39. STAMBLER BS; GOTTLIEB SS; SINGH BN; RAMANATHAN KB; OGILBY JD; ELLENBOGEN KA
      HEMODYNAMIC-EFFECTS OF INTRAVENOUS SEMATILIDE IN PATIENTS WITH CONGESTIVE-HEART-FAILURE - A CLASS-III ANTIARRHYTHMIC AGENT WITHOUT CARDIODEPRESSANT EFFECTS

      Journal of the American College of Cardiology
    40. WOOD MA; SIMPSON PM; LONDON WB; STAMBLER BS; HERRE JM; BERNSTEIN RC; ELLENBOGEN KA
      CIRCADIAN PATTERN OF VENTRICULAR TACHYARRHYTHMIAS IN PATIENTS WITH IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS

      Journal of the American College of Cardiology
    41. ELLENBOGEN KA; HAWTHORNE HR; BELZ MK; STAMBLER BS; CHERWEK ML; WOOD MA
      LATE OCCURRENCE OF INCESSANT ATRIAL TACHYCARDIA FOLLOWING THE MAZE PROCEDURE

      PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY
    42. GUO CJ; ELLENBOGEN KA; KAY GN; STAMBLER BS
      DEPENDENCE ON AUTONOMIC CONTROL OF ATRIAL-FLUTTER CYCLE LENGTH VARIABILITY - EVIDENCE FROM PATIENTS WITH HEART-TRANSPLANTATION

      Circulation
    43. LAWTON JS; ELLENBOGEN KA; WOOD MA; STAMBLER BS; HERRE JM; NATH S; BERNSTEIN RC; DIMARCO JP; HAINES DE; SZENTPETERY S; BAKER LD; DAMIANO RJ
      SENSING LEAD-RELATED COMPLICATIONS IN PATIENTS WITH TRANSVENOUS IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS - THE VIRGINIA ENDOTAK(TM) EXPERIENCE

      Circulation
    44. OLSOVSKY MR; BELZ MK; STAMBLER BS; WOOD MA; ELLENBOGEN KA
      DOES SELECTIVE SLOW PATHWAY ABLATION ALTER VAGAL INPUT TO THE FAST PATHWAY OF THE AV NODE

      Circulation
    45. GUO CJ; ELLENBOGEN KA; STAMBLER BS
      ELUCIDATING THE MECHANISM OF ATRIAL-FLUTTER CYCLE LENGTH VARIABILITY USING SPECTRAL-ANALYSIS TECHNIQUES

      Circulation
    46. CLEMO HF; STAMBLER BS; BAUMGARTEN CM
      PERSISTENT STRETCH-ACTIVATED CURRENT AND CELL-VOLUME IN CONGESTIVE-HEART-FAILURE

      Circulation
    47. ELLENBOGEN KA; EPSTEIN AE; WOOD MA; STAMBLER BS; KAY GN; PLUMB VJ; VOSHAGESTAHL L; HULL ML
      ARE MORE COMPLEX IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS ASSOCIATED WITH AN INCREASED MORTALITY LESSONS FROM THE ENDOTAK(R) CLINICAL-TRIALS

      Circulation
    48. WOOD MA; SIMPSON PM; STAMBLER BS; HERRE JM; BERNSTEIN RC; ELLENBOGEN KA
      LONG-TERM TEMPORAL PATTERNS OF VENTRICULAR TACHYARRHYTHMIAS

      Circulation
    49. LAWTON JS; ELLENBOGEN KA; WOOD MA; STAMBLER BS; SPRATT JA; WECHSLER AS; DAMIANO RJ
      CLINICAL-EXPERIENCE WITH NONTHORACOTOMY CARDIOVERTER-DEFIBRILLATORS

      The Annals of thoracic surgery
    50. ELLENBOGEN KA; STAMBLER BS; WOOD MA; MOHANTY PK
      EXAMINATION OF MECHANOELECTRICAL FEEDBACK IN THE TRANSPLANTED HUMAN HEART

      The American journal of cardiology
    51. ELLENBOGEN KA; DIAS VC; CARDELLO FP; STRAUSS WE; SIMONTON CA; POLLAK SJ; WOOD MA; STAMBLER BS
      SAFETY AND EFFICACY OF INTRAVENOUS DILTIAZEM IN ATRIAL-FIBRILLATION OR ATRIAL-FLUTTER

      The American journal of cardiology
    52. WOOD MA; STAMBLER BS; DAMIANO RJ; GREENWAY P; ELLENBOGEN KA
      LESSONS LEARNED FROM DATA LOGGING IN A MULTICENTER CLINICAL-TRIAL USING A LATE-GENERATION IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR

      Journal of the American College of Cardiology
    53. STAMBLER BS; WOOD MA; DAMIANO RJ; GREENWAY PS; SMUTKA ML; ELLENBOGEN KA; BATSFORD W; BAUERNFEIND R; BECKMAN K; BROWNSTEIN S; CASTLE L; DEERING T; ELLENBOGEN K; ESTES NAM; FRANKLIN J; FREIHLING T; HAISTY K; KEHOE R; LOVE C; LUCERI R; NACCARELLI G; PACIFICO A; PARSONNET V; PETROPOULOS T; SAKSENA S; SHARMA A; SINGER I; VENDITTI F; WALTER P; ZIPES D; DAVIS MJ; HELLESTRAND K; KUCHAR D; POWELL A; STAFFORD W; UTHER J; VOHRA J; DORIAN P; GULAMHUSEIN S; KERR CR; ROSENGARTEN M; ROY D; TANG ASL; WILLIAMS W; YEE R; MOLLER M; THOMSEN PEB; ALIOT E; LECLERQ JF; LEMAREC H; SCANU P; TOUBOUL P; BRACHMAN J; SEN S; TRESE N; DULK KD; BLOMSTROMLUNDQVIST C; CAMM AJ; COWAN C
      SENSING PACING LEAD COMPLICATIONS WITH A NEWER GENERATION IMPLANTABLECARDIOVERTER-DEFIBRILLATOR - WORLDWIDE EXPERIENCE FROM THE GUARDIAN-ATP-4210 CLINICAL-TRIAL

      Journal of the American College of Cardiology
    54. WOOD MA; SIMPSON PM; LONDON WB; STAMBLER BS; HERRE JM; BERNSTEIN RC; ELLEBOGEN KA
      CIRCADIAN PATTERN OF VENTRICULAR TACHYARRHYTHMIAS IN PATIENTS WITH IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS

      Journal of the American College of Cardiology
    55. ELLENBOGEN KA; WOOD MA; STAMBLER BS; WAKEFIELD LK; VANDERLUGE JT
      CONVERSION OF ATRIAL-FIBRILLATION AND FLUTTER BY INTRAVENOUS IBUTILLIDE - A MULTICENTER DOSE-RESPONSE STUDY

      Journal of the American College of Cardiology
    56. BELZ MK; STAMBLER BS; WOOD MA; ELLENBOGEN KA
      EFFECTS OF ENHANCED VAGAL TONE ON FAST AND SLOW PATHWAY CONDUCTION DURING AV NODAL REENTRANT TACHYCARDIA

      Journal of the American College of Cardiology
    57. GRUVER EJ; MORGAN JP; STAMBLER BS; GWATHMEY JK
      UNIFORMITY OF CALCIUM-CHANNEL NUMBER AND ISOMETRIC CONTRACTION IN HUMAN RIGHT AND LEFT-VENTRICULAR MYOCARDIUM

      Basic research in cardiology
    58. CLEMO HF; ELLENBOGEN KA; BELZ MK; WOOD MA; STAMBLER BS
      SAFETY OF PACEMAKER IMPLANTATION IN PATIENTS WITH TRANSVENOUS (NONTHORACOTOMY) IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS

      PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY
    59. CLEMO HF; BAUMGARTEN CM; STAMBLER BS; WOOD MA; ELLENBOGEN KA
      ATRIAL-NATRIURETIC-FACTOR - IMPLICATIONS FOR CARDIAC PACING AND ELECTROPHYSIOLOGY

      PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY
    60. MORILLO CA; TAYLOR JA; STAMBLER BS; WOOD MA; ECKBERG DL; ELLENBOGEN KA
      DIFFERENTIAL-EFFECTS OF VVI AND DDD PACING WITH VARIABLE ATRIOVENTRICULAR DELAYS ON MUSCLE SYMPATHETIC-NERVE ACTIVITY

      Circulation
    61. MORILLO CA; TAYLOR JA; STAMBLER BS; WOOD MA; ECKBERG DL; ELLENBOGEN KA
      DIFFERENTIAL-EFFECTS OF VVI AND DDD PACING WITH VARIABLE ATRIOVENTRICULAR DELAYS ON MUSCLE SYMPATHETIC-NERVE ACTIVITY

      Circulation
    62. STAMBLER BS; TURNER DA; GUO CJ; GUO GBF; ELLENBOGEN KA
      CHARACTERIZATION OF THE IN-VIVO CARDIAC ELECTROPHYSIOLOGIC EFFECTS OFATRIAL-NATRIURETIC-FACTOR (ANF)

      Circulation
    63. STAMBLER BS; TURNER DA; GUO CJ; GUO GBF; ELLENBOGEN KA
      CHARACTERIZATION OF THE IN-VIVO CARDIAC ELECTROPHYSIOLOGIC EFFECTS OFATRIAL-NATRIURETIC-FACTOR (ANF)

      Circulation
    64. STAMBLER BS; AKOSAH KO; MOHANTY PK; SIMON RC; SPERRY RE; CLEMO HF; BELZ MK; CYCAN A; WOOD MA; ELLENBOGEN KA
      DOBUTAMINE STRESS ELECTROPHYSIOLOGIC TESTING - ROLE OF MYOCARDIAL-ISCHEMIA IN INDUCIBILITY OF SUSTAINED VENTRICULAR ARRHYTHMIAS

      Circulation
    65. STAMBLER BS; AKOSAH KO; MOHANTY PK; SIMON RC; SPERRY RE; CLEMO HF; BELZ MK; CYCAN A; WOOD MA; ELLENBOGEN KA
      DOBUTAMINE STRESS ELECTROPHYSIOLOGIC TESTING - ROLE OF MYOCARDIAL-ISCHEMIA IN INDUCIBILITY OF SUSTAINED VENTRICULAR ARRHYTHMIAS

      Circulation
    66. GUO GBF; ELLENBOGEN KA; WOOD MA; GUO CJ; STAMBLER BS
      CONVERSION OF ATRIAL-FLUTTER BY IBUTILIDE IS ASSOCIATED WITH INCREASED ATRIAL CYCLE LENGTH VARIABILITY

      Circulation
    67. BLACKSHEAR JL; STAMBLER BS; STRAUSS WE; DIAS VC; BEACH CL; EBENER MK
      CONTROL OF HEART-RATE DURING TRANSITION FROM IV TO ORAL DILTIAZEM IN PATIENTS WITH RAPID ATRIAL-FIBRILLATION OR FLUTTER - RESULTS OF A MULTICENTER TRIAL

      Circulation
    68. GUO GBF; ELLENBOGEN KA; WOOD MA; GUO CJ; STAMBLER BS
      CONVERSION OF ATRIAL-FLUTTER BY IBUTILIDE IS ASSOCIATED WITH INCREASED ATRIAL CYCLE LENGTH VARIABILITY

      Circulation
    69. BLACKSHEAR JL; STAMBLER BS; STRAUSS WE; DIAS VC; BEACH CL; EBENER MK
      CONTROL OF HEART-RATE DURING TRANSITION FROM IV TO ORAL DILTIAZEM IN PATIENTS WITH RAPID ATRIAL-FIBRILLATION OR FLUTTER - RESULTS OF A MULTICENTER TRIAL

      Circulation
    70. WOOD MA; ELLENBOGEN KA; STAMBLER BS
      ATRIAL-FIBRILLATION FROM LIQUID PROTEIN-DIET

      The American heart journal
    71. HAWTHORNE HR; WOOD MA; STAMBLER BS; DAMIANO RJ; ELLENBOGEN KA
      CAN AMIODARONE PULMONARY TOXICITY BE PREDICTED IN PATIENTS UNDERGOINGIMPLANTABLE CARDIOVERTER-DEFIBRILLATOR IMPLANTATION

      PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY
    72. SPERRY RE; ELLENBOGEN KA; WOOD MA; BELZ MK; STAMBLER BS
      RADIOFREQUENCY CATHETER ABLATION OF SINUS NODE REENTRANT TACHYCARDIA

      PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY
    73. WOOD MA; SIMPSON PM; FARINA DR; STAMBLER BS; ELLENBOGEN KA
      THE TIME INTERVALS BETWEEN EPISODES OF VENTRICULAR TACHYARRHYTHMIAS IN PATIENTS WITH IMPLANTABLE DEFIBRILLATORS ARE NON-RANDOMLY DISTRIBUTED

      Circulation
    74. STAMBLER BS; BELZ MK; SPERRY RE; WOOD MA; DAMIANO RJ; ELLENBOGEN KA
      VENTILATION BASED DETERMINANTS OF TRANSTHORACIC IMPEDANCE TO INTERNALDC CARDIOVERSION

      Circulation
    75. STAMBLER BS; WOOD MA; BELZ MK; SPERRY RE; VANDERLUGT JT; ELLENBOGEN KA
      ELECTROPHYSIOLOGIC DETERMINANTS OF PHARMACOLOGICAL CONVERSION OF HUMAN ATRIAL-FIBRILLATION AND FLUTTER - ENHANCED EFFICACY OF IBUTILIDE A NEW CLASS-III ANTIARRHYTHMIC DRUG

      Circulation
    76. STAMBLER BS; KOMAMURA K; IHARA T; SHANNON RP
      ACUTE INTRAVENOUS COCAINE CAUSES TRANSIENT DEPRESSION FOLLOWED BY ENHANCED LEFT-VENTRICULAR FUNCTION IN CONSCIOUS DOGS

      Circulation


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 26/10/20 alle ore 13:45:18